EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.23.34 | Abortion, Habitual |
24464956 |
Role of cathepsin E in decidual macrophage of patients with recurrent miscarriage. |
causal interaction diagnostic usage ongoing research unassigned |
4 2 4 0 |
3.4.23.34 | Abortion, Spontaneous |
24464956 |
Role of cathepsin E in decidual macrophage of patients with recurrent miscarriage. |
causal interaction diagnostic usage ongoing research unassigned |
4 2 4 0 |
3.4.23.34 | Adenocarcinoma |
25649 |
The isolation and properties of a non-pepsin proteinase from human gastric mucosa. |
ongoing research unassigned |
2 0 |
3.4.23.34 | Adenocarcinoma |
1725947 |
Origins of the multiple cathepsin E transcripts observed in human gastric mucosa and gastric adenocarcinoma. |
ongoing research unassigned |
2 0 |
3.4.23.34 | Adenocarcinoma |
2674141 |
Human gastric cathepsin E. Predicted sequence, localization to chromosome 1, and sequence homology with other aspartic proteinases. |
ongoing research unassigned |
4 0 |
3.4.23.34 | Adenocarcinoma |
11129230 |
Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma. |
causal interaction diagnostic usage ongoing research unassigned |
4 4 1 0 |
3.4.23.34 | Adenocarcinoma |
12531480 |
An alternatively spliced variant of cathepsin E in human gastric adenocarcinoma cells. |
ongoing research unassigned |
3 0 |
3.4.23.34 | Adenocarcinoma |
12777211 |
An immunohistochemical study and review of potential markers of human intestinal M cells. |
causal interaction diagnostic usage ongoing research therapeutic application |
2 1 2 1 |
3.4.23.34 | Adenocarcinoma |
25348778 |
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma. |
therapeutic application unassigned |
1 0 |
3.4.23.34 | Adenocarcinoma |
27149201 |
Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 2 4 |